{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "HIV", "SARS-CoV-2", "central nervous system (CNS)", "dietary supplements", "drug delivery", "extracellular vesicles", "nutraceuticals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35205044", "DateRevised": {"Year": "2022", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "23"}], "Language": ["eng"], "ELocationID": ["177", "10.3390/biology11020177"], "Journal": {"ISSN": "2079-7737", "JournalIssue": {"Volume": "11", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "23"}}, "Title": "Biology", "ISOAbbreviation": "Biology (Basel)"}, "ArticleTitle": "Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality.", "Abstract": {"AbstractText": ["People living with HIV/AIDS (PLWHA) are at an increased risk of severe and critical COVID-19 infection. There is a steady increase in neurological complications associated with COVID-19 infection, exacerbating HIV-associated neurocognitive disorders (HAND) in PLWHA. Nutraceuticals, such as phytochemicals from medicinal plants and dietary supplements, have been used as adjunct therapies for many disease conditions, including viral infections. Appropriate use of these adjunct therapies with antiviral proprieties may be beneficial in treating and/or prophylaxis of neurological complications associated with these co-infections. However, most of these nutraceuticals have poor bioavailability and cannot cross the blood-brain barrier (BBB). To overcome this challenge, extracellular vesicles (EVs), biological nanovesicles, can be used. Due to their intrinsic features of biocompatibility, stability, and their ability to cross BBB, as well as inherent homing capabilities, EVs hold immense promise for therapeutic drug delivery to the brain. Therefore, in this review, we summarize the potential role of different nutraceuticals in reducing HIV- and COVID-19-associated neurological complications and the use of EVs as nutraceutical/drug delivery vehicles to treat HIV, COVID-19, and other brain disorders."]}, "AuthorList": [{"Identifier": ["0000-0002-9385-5985"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA."}], "LastName": "Kodidela", "ForeName": "Sunitha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA."}], "LastName": "Godse", "ForeName": "Sandip", "Initials": "S"}, {"Identifier": ["0000-0003-1735-7033"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA."}], "LastName": "Kumar", "ForeName": "Asit", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA."}], "LastName": "Nguyen", "ForeName": "Xuyen H", "Initials": "XH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Sciences Center, Nashville, TN 37211, USA."}], "LastName": "Cernasev", "ForeName": "Alina", "Initials": "A"}, {"Identifier": ["0000-0002-4439-9274"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA."}], "LastName": "Zhou", "ForeName": "Lina", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, 7465 Medical Research Building IV, 2215 Garland Avenue, Nashville, TN 37232, USA."}], "LastName": "Singh", "ForeName": "Ajay Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA."}], "LastName": "Bhat", "ForeName": "Hari K", "Initials": "HK"}, {"Identifier": ["0000-0001-7846-5674"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA."}], "LastName": "Kumar", "ForeName": "Santosh", "Initials": "S"}], "GrantList": [{"GrantID": "MH125670", "Acronym": "MH", "Agency": "NIMH NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biology (Basel)", "NlmUniqueID": "101587988", "ISSNLinking": "2079-7737"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Centers for Disease Control (CDC), Pneumocystis Pneumonia\u2014Los Angeles. Morb. Mortal. Wkly. Rep. 1981;30:250\u2013252.", "ArticleIdList": ["6265753"]}, {"Citation": "Hui D.S., Azhar E.I., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., Mchugh T.D., Memish Z.A., Drosten C., et al. The Continuing 2019-NCoV Epidemic Threat of Novel Coronaviruses to Global Health\u2014The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264\u2013266. doi: 10.1016/j.ijid.2020.01.009.", "ArticleIdList": ["10.1016/j.ijid.2020.01.009", "PMC7128332", "31953166"]}, {"Citation": "Wu J.T., Leung K., Leung G.M. Nowcasting and Forecasting the Potential Domestic and International Spread of the 2019-NCoV Outbreak Originating in Wuhan, China: A Modelling Study. Lancet. 2020;395:689\u2013697. doi: 10.1016/S0140-6736(20)30260-9.", "ArticleIdList": ["10.1016/S0140-6736(20)30260-9", "PMC7159271", "32014114"]}, {"Citation": "Lessons Learned from Health Disparities among African Americans in the HIV Epidemic: What to Expect for COVID-19 and Potential Approaches to Mitigate Health Disparity.  [(accessed on 18 October 2021)].  Available online:  https://www.semanticscholar.org/paper/Lessons-Learned-from-Health-Disparities-Among-in-to/3299c4c7700935a3fc5fecbf459a91ec9fd35277."}, {"Citation": "Clifford D.B., Ances B.M. HIV-Associated Neurocognitive Disorder. Lancet Infect. Dis. 2013;13:976\u2013986. doi: 10.1016/S1473-3099(13)70269-X.", "ArticleIdList": ["10.1016/S1473-3099(13)70269-X", "PMC4108270", "24156898"]}, {"Citation": "Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.-E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in Human and Mouse Brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.", "ArticleIdList": ["10.1084/jem.20202135", "PMC7808299", "33433624"]}, {"Citation": "Ramani A., M\u00fcller L., Ostermann P.N., Gabriel E., Abida-Islam P., M\u00fcller-Schiffmann A., Mariappan A., Goureau O., Gruell H., Walker A., et al. SARS-CoV-2 Targets Neurons of 3D Human Brain Organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.", "ArticleIdList": ["10.15252/embj.2020106230", "PMC7560208", "32876341"]}, {"Citation": "Romero-S\u00e1nchez C.M., D\u00edaz-Maroto I., Fern\u00e1ndez-D\u00edaz E., S\u00e1nchez-Larsen \u00c1., Layos-Romero A., Garc\u00eda-Garc\u00eda J., Gonz\u00e1lez E., Redondo-Pe\u00f1as I., Perona-Moratalla A.B., Del Valle-P\u00e9rez J.A., et al. Neurologic Manifestations in Hospitalized Patients with COVID-19: The ALBACOVID Registry. Neurology. 2020;95:e1060\u2013e1070. doi: 10.1212/WNL.0000000000009937.", "ArticleIdList": ["10.1212/WNL.0000000000009937", "PMC7668545", "32482845"]}, {"Citation": "Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological Manifestations of COVID-19 and Other Coronavirus Infections: A Systematic Review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.", "ArticleIdList": ["10.1016/j.clineuro.2020.105921", "PMC7227498", "32422545"]}, {"Citation": "Liotta E.M., Batra A., Clark J.R., Shlobin N.A., Hoffman S.C., Orban Z.S., Koralnik I.J. Frequent Neurologic Manifestations and Encephalopathy-Associated Morbidity in COVID-19 Patients. Ann. Clin. Transl. Neurol. 2020;7:2221\u20132230. doi: 10.1002/acn3.51210.", "ArticleIdList": ["10.1002/acn3.51210", "PMC7664279", "33016619"]}, {"Citation": "Blanco J.L., Ambrosioni J., Garcia F., Mart\u00ednez E., Soriano A., Mallolas J., Miro J.M. COVID-19 in HIV Investigators COVID-19 in Patients with HIV: Clinical Case Series. Lancet HIV. 2020;7:e314\u2013e316. doi: 10.1016/S2352-3018(20)30111-9.", "ArticleIdList": ["10.1016/S2352-3018(20)30111-9", "PMC7159872", "32304642"]}, {"Citation": "Guo W., Ming F., Feng Y., Zhang Q., Mo P., Liu L., Gao M., Tang W., Liang K. Patterns of HIV and SARS-CoV-2 Co-Infection in Wuhan, China. J. Int. AIDS Soc. 2020;23:e25568. doi: 10.1002/jia2.25568.", "ArticleIdList": ["10.1002/jia2.25568", "PMC7323012", "32697865"]}, {"Citation": "Kumar S., Zhi K., Mukherji A., Gerth K. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19. Viruses. 2020;12:486. doi: 10.3390/v12050486.", "ArticleIdList": ["10.3390/v12050486", "PMC7290948", "32357553"]}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-NCoV) in Vitro. Cell Res. 2020;30:269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Choy K.-T., Wong A.Y.-L., Kaewpreedee P., Sia S.F., Chen D., Hui K.P.Y., Chu D.K.W., Chan M.C.W., Cheung P.P.-H., Huang X., et al. Remdesivir, Lopinavir, Emetine, and Homoharringtonine Inhibit SARS-CoV-2 Replication in Vitro. Antivir. Res. 2020;178:104786. doi: 10.1016/j.antiviral.2020.104786.", "ArticleIdList": ["10.1016/j.antiviral.2020.104786", "PMC7127386", "32251767"]}, {"Citation": "de Wilde A.H., Jochmans D., Posthuma C.C., Zevenhoven-Dobbe J.C., van Nieuwkoop S., Bestebroer T.M., van den Hoogen B.G., Neyts J., Snijder E.J. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture. Antimicrob. Agents Chemother. 2014;58:4875\u20134884. doi: 10.1128/AAC.03011-14.", "ArticleIdList": ["10.1128/AAC.03011-14", "PMC4136071", "24841269"]}, {"Citation": "Office of the Commissioner  FDA Approves First Treatment for COVID-19.  [(accessed on 26 October 2021)]; Available online:  https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19."}, {"Citation": "Pan H., Peto R., Henao-Restrepo A.-M., Preziosi M.-P., Sathiyamoorthy V., Abdool Karim Q., Alejandria M.M., Hern\u00e1ndez Garc\u00eda C., Kieny M.-P., WHO Solidarity Trial Consortium et al. Repurposed Antiviral Drugs for COVID-19\u2014Interim WHO Solidarity Trial Results. N. Engl. J. Med. 2021;384:497\u2013511. doi: 10.1056/NEJMoa2023184.", "ArticleIdList": ["10.1056/NEJMoa2023184", "PMC7727327", "33264556"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19. N. Engl. J. Med. 2020;382:1787\u20131799. doi: 10.1056/NEJMoa2001282.", "ArticleIdList": ["10.1056/NEJMoa2001282", "PMC7121492", "32187464"]}, {"Citation": "Kanwugu O.N., Adadi P. HIV/SARS-CoV-2 Coinfection: A Global Perspective. J. Med. Virol. 2021;93:726\u2013732. doi: 10.1002/jmv.26321.", "ArticleIdList": ["10.1002/jmv.26321", "PMC7404432", "32692406"]}, {"Citation": "WHO Warns That HIV Infection Increases Risk of Severe and Critical COVID-19.  [(accessed on 26 October 2021)].  Available online:  https://www.who.int/news/item/15-07-2021-who-warns-that-hiv-infection-increases-risk-of-severe-and-critical-covid-19."}, {"Citation": "Ho H.-E., Peluso M.J., Margus C., Matias Lopes J.P., He C., Gaisa M.M., Osorio G., Aberg J.A., Mullen M.P. Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People with Human Immunodeficiency Virus. J. Infect. Dis. 2021;223:403\u2013408. doi: 10.1093/infdis/jiaa380.", "ArticleIdList": ["10.1093/infdis/jiaa380", "PMC7337732", "32601704"]}, {"Citation": "Ssentongo P., Heilbrunn E.S., Ssentongo A.E., Advani S., Chinchilli V.M., Nunez J.J., Du P. Epidemiology and Outcomes of COVID-19 in HIV-Infected Individuals: A Systematic Review and Meta-Analysis. Sci. Rep. 2021;11:6283. doi: 10.1038/s41598-021-85359-3.", "ArticleIdList": ["10.1038/s41598-021-85359-3", "PMC7973415", "33737527"]}, {"Citation": "CDC  COVID-19 Breakthrough Case Investigations and Reporting.  [(accessed on 26 October 2021)]; Available online:  https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html."}, {"Citation": "Bergwerk M., Gonen T., Lustig Y., Amit S., Lipsitch M., Cohen C., Mandelboim M., Levin E.G., Rubin C., Indenbaum V., et al. COVID-19 Breakthrough Infections in Vaccinated Health Care Workers. N. Engl. J. Med. 2021;385:1474\u20131484. doi: 10.1056/NEJMoa2109072.", "ArticleIdList": ["10.1056/NEJMoa2109072", "PMC8362591", "34320281"]}, {"Citation": "Waheed S., Bayas A., Hindi F., Rizvi Z., Espinosa P.S. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus. 2021;13:e13426. doi: 10.7759/cureus.13426.", "ArticleIdList": ["10.7759/cureus.13426", "PMC7978140", "33758714"]}, {"Citation": "Colella G., Orlandi M., Cirillo N. Bell\u2019s Palsy Following COVID-19 Vaccination. J. Neurol. 2021;268:3589\u20133591. doi: 10.1007/s00415-021-10462-4.", "ArticleIdList": ["10.1007/s00415-021-10462-4", "PMC7897359", "33611630"]}, {"Citation": "Einstein E.H., Shahzadi A., Desir L., Katz J., Boockvar J., D\u2019Amico R. New-Onset Neurologic Symptoms and Related Neuro-Oncologic Lesions Discovered After COVID-19 Vaccination: Two Neurosurgical Cases and Review of Post-Vaccine Inflammatory Responses. Cureus. 2021;13:e15664. doi: 10.7759/cureus.15664.", "ArticleIdList": ["10.7759/cureus.15664", "PMC8281785", "34277256"]}, {"Citation": "Braverman N.E., Moser A.B. Functions of Plasmalogen Lipids in Health and Disease. Biochim. Biophys. Acta. 2012;1822:1442\u20131452. doi: 10.1016/j.bbadis.2012.05.008.", "ArticleIdList": ["10.1016/j.bbadis.2012.05.008", "22627108"]}, {"Citation": "Dei Cas M., Ottolenghi S., Morano C., Rinaldo R., Roda G., Chiumello D., Centanni S., Samaja M., Paroni R. Link between Serum Lipid Signature and Prognostic Factors in COVID-19 Patients. Sci. Rep. 2021;11:21633. doi: 10.1038/s41598-021-00755-z.", "ArticleIdList": ["10.1038/s41598-021-00755-z", "PMC8568966", "34737330"]}, {"Citation": "Schwarz B., Sharma L., Roberts L., Peng X., Bermejo S., Leighton I., Massana A.C., Farhadian S., Ko A.I., Yale IMPACT Team et al. Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome Resulting in Dysregulation of Eicosanoid Immune Mediators. medRxiv. 2020 doi: 10.4049/jimmunol.2001025.", "ArticleIdList": ["10.4049/jimmunol.2001025", "PMC7962598", "33277388"]}, {"Citation": "Deng Y., Angelova A. Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens. Front. Cell Dev. Biol. 2021;9:630242. doi: 10.3389/fcell.2021.630242.", "ArticleIdList": ["10.3389/fcell.2021.630242", "PMC8006408", "33791293"]}, {"Citation": "Chapman R.L., Andurkar S.V. A Review of Natural Products, Their Effects on SARS-CoV-2 and Their Utility as Lead Compounds in the Discovery of Drugs for the Treatment of COVID-19. Med. Chem. Res. 2021;31:40\u201351. doi: 10.1007/s00044-021-02826-2.", "ArticleIdList": ["10.1007/s00044-021-02826-2", "PMC8636070", "34873386"]}, {"Citation": "Costagliola G., Nuzzi G., Spada E., Comberiati P., Verduci E., Peroni D.G. Nutraceuticals in Viral Infections: An Overview of the Immunomodulating Properties. Nutrients. 2021;13:2410. doi: 10.3390/nu13072410.", "ArticleIdList": ["10.3390/nu13072410", "PMC8308811", "34371920"]}, {"Citation": "McCarty M.F., DiNicolantonio J.J. Nutraceuticals Have Potential for Boosting the Type 1 Interferon Response to RNA Viruses Including Influenza and Coronavirus. Prog. Cardiovasc. Dis. 2020;63:383\u2013385. doi: 10.1016/j.pcad.2020.02.007.", "ArticleIdList": ["10.1016/j.pcad.2020.02.007", "PMC7130854", "32061635"]}, {"Citation": "Ranjit S., Sinha N., Kodidela S., Kumar S. Benzo(a)Pyrene in Cigarette Smoke Enhances HIV-1 Replication through NF-\u039aB Activation via CYP-Mediated Oxidative Stress Pathway. Sci. Rep. 2018;8:10394. doi: 10.1038/s41598-018-28500-z.", "ArticleIdList": ["10.1038/s41598-018-28500-z", "PMC6039513", "29991690"]}, {"Citation": "Kodidela S., Sinha N., Kumar A., Kumar S. Anti-HIV Activity of Cucurbitacin-d against Cigarette Smoke Condensate-Induced HIV Replication in the U1 Macrophages. Viruses. 2021;13:1004. doi: 10.3390/v13061004.", "ArticleIdList": ["10.3390/v13061004", "PMC8228815", "34072078"]}, {"Citation": "Derosa G., Maffioli P., D\u2019Angelo A., Di Pierro F. Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications. Front. Immunol. 2021;12:582556. doi: 10.3389/fimmu.2021.582556.", "ArticleIdList": ["10.3389/fimmu.2021.582556", "PMC8273380", "34262553"]}, {"Citation": "Lordan R. Dietary Supplements and Nutraceuticals Market Growth during the Coronavirus Pandemic\u2014Implications for Consumers and Regulatory Oversight. PharmaNutrition. 2021;18:100282. doi: 10.1016/j.phanu.2021.100282.", "ArticleIdList": ["10.1016/j.phanu.2021.100282", "PMC8416287", "34513589"]}, {"Citation": "Park J.-Y., Yuk H.J., Ryu H.W., Lim S.H., Kim K.S., Park K.H., Ryu Y.B., Lee W.S. Evaluation of Polyphenols from Broussonetia papyrifera as Coronavirus Protease Inhibitors. J. Enzym. Inhib. Med. Chem. 2017;32:504\u2013515. doi: 10.1080/14756366.2016.1265519.", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Yu M.-S., Lee J., Lee J.M., Kim Y., Chin Y.-W., Jee J.-G., Keum Y.-S., Jeong Y.-J. Identification of Myricetin and Scutellarein as Novel Chemical Inhibitors of the SARS Coronavirus Helicase, NsP13. Bioorg. Med. Chem. Lett. 2012;22:4049\u20134054. doi: 10.1016/j.bmcl.2012.04.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Huang K., Shi C., Min J., Li L., Zhu T., Yu H., Deng H. Study on the Mechanism of Curcumin Regulating Lung Injury Induced by Outdoor Fine Particulate Matter (PM2.5) Mediat. Inflamm. 2019;2019:e8613523. doi: 10.1155/2019/8613523.", "ArticleIdList": ["10.1155/2019/8613523", "PMC6721509", "31530996"]}, {"Citation": "CDC  COVID-19 and Your Health.  [(accessed on 9 November 2021)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/index.html."}, {"Citation": "Nutraceuticals Market Size, Share & Trends Analysis Report by Product (Dietary Supplements, Functional Food, Functional Beverages), by Region, and Segment Forecasts, 2020\u20132028.  [(accessed on 26 October 2021)].  Available online:  https://www.researchandmarkets.com/reports/4452005/nutraceuticals-market-size-share-and-trends."}, {"Citation": "Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J.-L., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D., et al. Angiotensin-Converting Enzyme 2 (ACE2), SARS-CoV-2 and the Pathophysiology of Coronavirus Disease 2019 (COVID-19) J. Pathol. 2020;251:228\u2013248. doi: 10.1002/path.5471.", "ArticleIdList": ["10.1002/path.5471", "PMC7276767", "32418199"]}, {"Citation": "Mirzaei H., McFarland W., Karamouzian M., Sharifi H. COVID-19 among People Living with HIV: A Systematic Review. AIDS Behav. 2021;25:85\u201392. doi: 10.1007/s10461-020-02983-2.", "ArticleIdList": ["10.1007/s10461-020-02983-2", "PMC7391049", "32734438"]}, {"Citation": "Antiretroviral Therapy Cohort Collaboration Life Expectancy of Individuals on Combination Antiretroviral Therapy in High-Income Countries: A Collaborative Analysis of 14 Cohort Studies. Lancet. 2008;372:293\u2013299. doi: 10.1016/S0140-6736(08)61113-7.", "ArticleIdList": ["10.1016/S0140-6736(08)61113-7", "PMC3130543", "18657708"]}, {"Citation": "Mills E.J., Bakanda C., Birungi J., Chan K., Ford N., Cooper C.L., Nachega J.B., Dybul M., Hogg R.S. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis from Uganda. Ann. Intern. Med. 2011;155:209\u2013216. doi: 10.7326/0003-4819-155-4-201108160-00358.", "ArticleIdList": ["10.7326/0003-4819-155-4-201108160-00358", "21768555"]}, {"Citation": "Life Expectancy for People Living with HIV.  [(accessed on 26 October 2021)].  Available online:  https://www.aidsmap.com/about-hiv/life-expectancy-people-living-hiv."}, {"Citation": "Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., et al. Updated Research Nosology for HIV-Associated Neurocognitive Disorders. Neurology. 2007;69:1789\u20131799. doi: 10.1212/01.WNL.0000287431.88658.8b.", "ArticleIdList": ["10.1212/01.WNL.0000287431.88658.8b", "PMC4472366", "17914061"]}, {"Citation": "Saylor D., Dickens A.M., Sacktor N., Haughey N., Slusher B., Pletnikov M., Mankowski J.L., Brown A., Volsky D.J., McArthur J.C. HIV-Associated Neurocognitive Disorder\u2014Pathogenesis and Prospects for Treatment. Nat. Rev. Neurol. 2016;12:234\u2013248. doi: 10.1038/nrneurol.2016.27.", "ArticleIdList": ["10.1038/nrneurol.2016.27", "PMC4937456", "26965674"]}, {"Citation": "Grant I., Franklin D.R., Deutsch R., Woods S.P., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Collier A.C., et al. Asymptomatic HIV-Associated Neurocognitive Impairment Increases Risk for Symptomatic Decline. Neurology. 2014;82:2055\u20132062. doi: 10.1212/WNL.0000000000000492.", "ArticleIdList": ["10.1212/WNL.0000000000000492", "PMC4118496", "24814848"]}, {"Citation": "Eggers C., Arendt G., Hahn K., Husstedt I.W., Maschke M., Neuen-Jacob E., Obermann M., Rosenkranz T., Schielke E., Straube E., et al. HIV-1-Associated Neurocognitive Disorder: Epidemiology, Pathogenesis, Diagnosis, and Treatment. J. Neurol. 2017;264:1715\u20131727. doi: 10.1007/s00415-017-8503-2.", "ArticleIdList": ["10.1007/s00415-017-8503-2", "PMC5533849", "28567537"]}, {"Citation": "Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683\u2013690. doi: 10.1001/jamaneurol.2020.1127.", "ArticleIdList": ["10.1001/jamaneurol.2020.1127", "PMC7149362", "32275288"]}, {"Citation": "Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., et al. Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Nature. 2003;426:450\u2013454. doi: 10.1038/nature02145.", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell Entry Mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727\u201311734. doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Zamorano Cuervo N., Grandvaux N. ACE2: Evidence of Role as Entry Receptor for SARS-CoV-2 and Implications in Comorbidities. eLife. 2020;9:e61390. doi: 10.7554/eLife.61390.", "ArticleIdList": ["10.7554/eLife.61390", "PMC7652413", "33164751"]}, {"Citation": "Xia H., Lazartigues E. Angiotensin-Converting Enzyme 2 in the Brain: Properties and Future Directions. J. Neurochem. 2008;107:1482\u20131494. doi: 10.1111/j.1471-4159.2008.05723.x.", "ArticleIdList": ["10.1111/j.1471-4159.2008.05723.x", "PMC2667944", "19014390"]}, {"Citation": "Chen R., Wang K., Yu J., Howard D., French L., Chen Z., Wen C., Xu Z. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front. Neurol. 2020;11:573095. doi: 10.3389/fneur.2020.573095.", "ArticleIdList": ["10.3389/fneur.2020.573095", "PMC7855591", "33551947"]}, {"Citation": "Maury A., Lyoubi A., Peiffer-Smadja N., de Broucker T., Meppiel E. Neurological Manifestations Associated with SARS-CoV-2 and Other Coronaviruses: A Narrative Review for Clinicians. Rev. Neurol. 2021;177:51\u201364. doi: 10.1016/j.neurol.2020.10.001.", "ArticleIdList": ["10.1016/j.neurol.2020.10.001", "PMC7832485", "33446327"]}, {"Citation": "Karada\u015f \u00d6., \u00d6zt\u00fcrk B., Sonkaya A.R. A Prospective Clinical Study of Detailed Neurological Manifestations in Patients with COVID-19. Neurol. Sci. 2020;41:1991\u20131995. doi: 10.1007/s10072-020-04547-7.", "ArticleIdList": ["10.1007/s10072-020-04547-7", "PMC7316428", "32588367"]}, {"Citation": "Collantes M.E.V., Espiritu A.I., Sy M.C.C., Anlacan V.M.M., Jamora R.D.G. Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis. Can. J. Neurol. Sci. 2021;48:66\u201376. doi: 10.1017/cjn.2020.146.", "ArticleIdList": ["10.1017/cjn.2020.146", "PMC7492583", "32665054"]}, {"Citation": "Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., Ueno M., Sakata H., Kondo K., Myose N., et al. A First Case of Meningitis/Encephalitis Associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55\u201358. doi: 10.1016/j.ijid.2020.03.062.", "ArticleIdList": ["10.1016/j.ijid.2020.03.062", "PMC7195378", "32251791"]}, {"Citation": "Camdessanche J.-P., Morel J., Pozzetto B., Paul S., Tholance Y., Botelho-Nevers E. COVID-19 May Induce Guillain-Barr\u00e9 Syndrome. Rev. Neurol. 2020;176:516\u2013518. doi: 10.1016/j.neurol.2020.04.003.", "ArticleIdList": ["10.1016/j.neurol.2020.04.003", "PMC7158797", "32334841"]}, {"Citation": "Ooi S.-L., Pak S.-C. Nutraceuticals in Immune Function. Molecules. 2021;26:5310. doi: 10.3390/molecules26175310.", "ArticleIdList": ["10.3390/molecules26175310", "PMC8433708", "34500743"]}, {"Citation": "Liu L., Liu C., Wang Y., Wang P., Li Y., Li B. Herbal Medicine for Anxiety, Depression and Insomnia. Curr. Neuropharmacol. 2015;13:481\u2013493. doi: 10.2174/1570159X1304150831122734.", "ArticleIdList": ["10.2174/1570159X1304150831122734", "PMC4790408", "26412068"]}, {"Citation": "Liperoti R., Vetrano D.L., Bernabei R., Onder G. Herbal Medications in Cardiovascular Medicine. J. Am. Coll. Cardiol. 2017;69:1188\u20131199. doi: 10.1016/j.jacc.2016.11.078.", "ArticleIdList": ["10.1016/j.jacc.2016.11.078", "28254182"]}, {"Citation": "Shahrajabian M.H., Sun W., Cheng Q. Traditional Herbal Medicine for the Prevention and Treatment of Cold and Flu in the Autumn of 2020, Overlapped with COVID-19. Nat. Prod. Commun. 2020;15:1\u201310. doi: 10.1177/1934578X20951431.", "ArticleIdList": ["10.1177/1934578X20951431"]}, {"Citation": "Hemil\u00e4 H. Vitamin C and Infections. Nutrients. 2017;9:339. doi: 10.3390/nu9040339.", "ArticleIdList": ["10.3390/nu9040339", "PMC5409678", "28353648"]}, {"Citation": "Taha R., Abureesh S., Alghamdi S., Hassan R.Y., Cheikh M.M., Bagabir R.A., Almoallim H., Abdulkhaliq A. The Relationship between Vitamin D and Infections Including COVID-19: Any Hopes? Int. J. Gen. Med. 2021;14:3849\u20133870. doi: 10.2147/IJGM.S317421.", "ArticleIdList": ["10.2147/IJGM.S317421", "PMC8318784", "34335050"]}, {"Citation": "Annweiler C., Beaudenon M., Gautier J., Simon R., Dub\u00e9e V., Gonsard J., Parot-Schinkel E., COVIT-TRIAL Study Group COVID-19 and High-Dose VITamin D Supplementation TRIAL in High-Risk Older Patients (COVIT-TRIAL): Study Protocol for a Randomized Controlled Trial. Trials. 2020;21:1031. doi: 10.1186/s13063-020-04928-5.", "ArticleIdList": ["10.1186/s13063-020-04928-5", "PMC7768266", "33371905"]}, {"Citation": "Bae M., Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules. 2020;25:5346. doi: 10.3390/molecules25225346.", "ArticleIdList": ["10.3390/molecules25225346", "PMC7696052", "33207753"]}, {"Citation": "Mercola J., Grant W.B., Wagner C.L. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients. 2020;12:3361. doi: 10.3390/nu12113361.", "ArticleIdList": ["10.3390/nu12113361", "PMC7692080", "33142828"]}, {"Citation": "Marcinowska-Suchowierska E., Kupisz-Urba\u0144ska M., \u0141ukaszkiewicz J., P\u0142udowski P., Jones G. Vitamin D Toxicity\u2014A Clinical Perspective. Front. Endocrinol. 2018;9:550. doi: 10.3389/fendo.2018.00550.", "ArticleIdList": ["10.3389/fendo.2018.00550", "PMC6158375", "30294301"]}, {"Citation": "Cerullo G., Negro M., Parimbelli M., Pecoraro M., Perna S., Liguori G., Rondanelli M., Cena H., D\u2019Antona G. The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19. Front. Immunol. 2020;11:574029. doi: 10.3389/fimmu.2020.574029.", "ArticleIdList": ["10.3389/fimmu.2020.574029", "PMC7655735", "33193359"]}, {"Citation": "Holford P., Carr A.C., Jovic T.H., Ali S.R., Whitaker I.S., Marik P.E., Smith A.D. Vitamin C\u2014An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients. 2020;12:3760. doi: 10.3390/nu12123760.", "ArticleIdList": ["10.3390/nu12123760", "PMC7762433", "33297491"]}, {"Citation": "Hern\u00e1ndez A., Papadakos P.J., Torres A., Gonz\u00e1lez D.A., Vives M., Ferrando C., Baeza J. Two Known Therapies Could Be Useful as Adjuvant Therapy in Critical Patients Infected by COVID-19. Rev. Esp. Anestesiol. Reanim. 2020;67:245\u2013252. doi: 10.1016/j.redar.2020.03.004.", "ArticleIdList": ["10.1016/j.redar.2020.03.004", "PMC7156242", "32303365"]}, {"Citation": "Colunga Biancatelli R.M.L., Berrill M., Catravas J.D., Marik P.E. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19) Front. Immunol. 2020;11:1451. doi: 10.3389/fimmu.2020.01451.", "ArticleIdList": ["10.3389/fimmu.2020.01451", "PMC7318306", "32636851"]}, {"Citation": "JamaliMoghadamSiahkali S., Zarezade B., Koolaji S., SeyedAlinaghi S., Zendehdel A., Tabarestani M., Sekhavati Moghadam E., Abbasian L., Dehghan Manshadi S.A., Salehi M., et al. Safety and Effectiveness of High-Dose Vitamin C in Patients with COVID-19: A Randomized Open-Label Clinical Trial. Eur. J. Med. Res. 2021;26:20. doi: 10.1186/s40001-021-00490-1.", "ArticleIdList": ["10.1186/s40001-021-00490-1", "PMC7877333", "33573699"]}, {"Citation": "Salazar K., Mart\u00ednez F., P\u00e9rez-Mart\u00edn M., Cifuentes M., Trigueros L., Ferrada L., Espinoza F., Saldivia N., Bertinat R., Forman K., et al. SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies. Mol. Neurobiol. 2018;55:5439\u20135452. doi: 10.1007/s12035-017-0762-5.", "ArticleIdList": ["10.1007/s12035-017-0762-5", "28942474"]}, {"Citation": "Song J., Park J., Kim J.H., Choi J.Y., Kim J.Y., Lee K.M., Lee J.E. Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in Vivo Study. Exp. Neurobiol. 2015;24:41\u201354. doi: 10.5607/en.2015.24.1.41.", "ArticleIdList": ["10.5607/en.2015.24.1.41", "PMC4363333", "25792869"]}, {"Citation": "Makinde O., Rotimi K., Ikumawoyi V., Adeyemo T., Olayemi S. Effect of Vitamin A and Vitamin C Supplementation on Oxidative Stress in HIV and HIV-TB Co-Infection at Lagos University Teaching Hospital (LUTH) Nigeria. Afr. Health Sci. 2017;17:308\u2013314. doi: 10.4314/ahs.v17i2.3.", "ArticleIdList": ["10.4314/ahs.v17i2.3", "PMC5637014", "29062324"]}, {"Citation": "Oliveira K.F., Cunha D.F., Weffort V.R.S. Analysis of Serum and Supplemented Vitamin C and Oxidative Stress in HIV-Infected Children and Adolescents. J. Pediatr. 2011;87:517\u2013522. doi: 10.2223/JPED.2141.", "ArticleIdList": ["10.2223/JPED.2141", "22057470"]}, {"Citation": "Bordes C., Leguelinel-Blache G., Lavigne J.-P., Mauboussin J.-M., Laureillard D., Faure H., Rouanet I., Sotto A., Loubet P. Interactions between Antiretroviral Therapy and Complementary and Alternative Medicine: A Narrative Review. Clin. Microbiol. Infect. 2020;26:1161\u20131170. doi: 10.1016/j.cmi.2020.04.019.", "ArticleIdList": ["10.1016/j.cmi.2020.04.019", "32360208"]}, {"Citation": "Ibrahim M.A., Ramadan H.H., Mohammed R.N. Evidence That Ginkgo Biloba Could Use in the Influenza and Coronavirus COVID-19 Infections. J. Basic Clin. Physiol. Pharm. 2021;32:131\u2013143. doi: 10.1515/jbcpp-2020-0310.", "ArticleIdList": ["10.1515/jbcpp-2020-0310", "33594843"]}, {"Citation": "L\u00fc J.-M., Yan S., Jamaluddin S., Weakley S.M., Liang Z., Siwak E.B., Yao Q., Chen C. Ginkgolic Acid Inhibits HIV Protease Activity and HIV Infection in Vitro. Med. Sci. Monit. 2012;18:BR293\u2013BR298. doi: 10.12659/MSM.883261.", "ArticleIdList": ["10.12659/MSM.883261", "PMC3560711", "22847190"]}, {"Citation": "Borenstein R., Hanson B.A., Markosyan R.M., Gallo E.S., Narasipura S.D., Bhutta M., Shechter O., Lurain N.S., Cohen F.S., Al-Harthi L., et al. Ginkgolic Acid Inhibits Fusion of Enveloped Viruses. Sci. Rep. 2020;10:4746. doi: 10.1038/s41598-020-61700-0.", "ArticleIdList": ["10.1038/s41598-020-61700-0", "PMC7075884", "32179788"]}, {"Citation": "Zou W., Kim B.O., Zhou B.Y., Liu Y., Messing A., He J.J. Protection against Human Immunodeficiency Virus Type 1 Tat Neurotoxicity by Ginkgo Biloba Extract EGb 761 Involving Glial Fibrillary Acidic Protein. Am. J. Pathol. 2007;171:1923\u20131935. doi: 10.2353/ajpath.2007.070333.", "ArticleIdList": ["10.2353/ajpath.2007.070333", "PMC2111115", "18055541"]}, {"Citation": "Mango D., Weisz F., Nistic\u00f2 R. Ginkgolic Acid Protects against A\u03b2-Induced Synaptic Dysfunction in the Hippocampus. Front. Pharm. 2016;7:401. doi: 10.3389/fphar.2016.00401.", "ArticleIdList": ["10.3389/fphar.2016.00401", "PMC5080287", "27833555"]}, {"Citation": "Varga E., Juh\u00e1sz G., Bozs\u00f3 Z., Penke B., F\u00fcl\u00f6p L., Szegedi V. Amyloid-\u03921-42 Disrupts Synaptic Plasticity by Altering Glutamate Recycling at the Synapse. J. Alzheimer\u2019s Dis. 2015;45:449\u2013456. doi: 10.3233/JAD-142367.", "ArticleIdList": ["10.3233/JAD-142367", "25547631"]}, {"Citation": "Xiong Y., Zhu G.-H., Wang H.-N., Hu Q., Chen L.-L., Guan X.-Q., Li H.-L., Chen H.-Z., Tang H., Ge G.-B. Discovery of Naturally Occurring Inhibitors against SARS-CoV-2 3CLpro from Ginkgo Biloba Leaves via Large-Scale Screening. Fitoterapia. 2021;152:104909. doi: 10.1016/j.fitote.2021.104909.", "ArticleIdList": ["10.1016/j.fitote.2021.104909", "PMC8061081", "33894315"]}, {"Citation": "Wickizer V.D. Coffee, Tea, and Cocoa: An Economic and Political Analysis. Stanford University Press; Redwood City, CA, USA: 1951."}, {"Citation": "Yiannakopoulou E.C. Recent Patents on Antibacterial, Antifungal and Antiviral Properties of Tea. Recent Pat. Antiinfect. Drug Discov. 2012;7:60\u201365. doi: 10.2174/157489112799829738.", "ArticleIdList": ["10.2174/157489112799829738", "22353001"]}, {"Citation": "Banerjee S., Chatterjee J. Efficient Extraction Strategies of Tea (Camellia sinensis) Biomolecules. J. Food Sci. Technol. 2015;52:3158\u20133168. doi: 10.1007/s13197-014-1487-3.", "ArticleIdList": ["10.1007/s13197-014-1487-3", "PMC4444893", "26028699"]}, {"Citation": "Song J.-M., Lee K.-H., Seong B.-L. Antiviral Effect of Catechins in Green Tea on Influenza Virus. Antivir. Res. 2005;68:66\u201374. doi: 10.1016/j.antiviral.2005.06.010.", "ArticleIdList": ["10.1016/j.antiviral.2005.06.010", "16137775"]}, {"Citation": "Giunta B., Obregon D., Hou H., Zeng J., Sun N., Nikolic V., Ehrhart J., Shytle D., Fernandez F., Tan J. EGCG Mitigates Neurotoxicity Mediated by HIV-1 Proteins Gp120 and Tat in the Presence of IFN-Gamma: Role of JAK/STAT1 Signaling and Implications for HIV-Associated Dementia. Brain Res. 2006;1123:216\u2013225. doi: 10.1016/j.brainres.2006.09.057.", "ArticleIdList": ["10.1016/j.brainres.2006.09.057", "PMC4487677", "17078933"]}, {"Citation": "Guo L., Xing Y., Pan R., Jiang M., Gong Z., Lin L., Wang J., Xiong G., Dong J. Curcumin Protects Microglia and Primary Rat Cortical Neurons against HIV-1 Gp120-Mediated Inflammation and Apoptosis. PLoS ONE. 2013;8:e70565. doi: 10.1371/journal.pone.0070565.", "ArticleIdList": ["10.1371/journal.pone.0070565", "PMC3735595", "23936448"]}, {"Citation": "Rrapo E., Zhu Y., Tian J., Hou H., Smith A., Fernandez F., Tan J., Giunta B. Green Tea-EGCG Reduces GFAP Associated Neuronal Loss in HIV-1 Tat Transgenic Mice. Am. J. Transl. Res. 2009;1:72\u201379.", "ArticleIdList": ["PMC2776283", "19966940"]}, {"Citation": "Nath S., Bachani M., Harshavardhana D., Steiner J.P. Catechins Protect Neurons against Mitochondrial Toxins and HIV Proteins via Activation of the BDNF Pathway. J. Neurovirol. 2012;18:445\u2013455. doi: 10.1007/s13365-012-0122-1.", "ArticleIdList": ["10.1007/s13365-012-0122-1", "22886603"]}, {"Citation": "Lee J.W., Lee Y.K., Ban J.O., Ha T.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Green Tea (-)-Epigallocatechin-3-Gallate Inhibits Beta-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-KappaB Pathways in Mice. J. Nutr. 2009;139:1987\u20131993. doi: 10.3945/jn.109.109785.", "ArticleIdList": ["10.3945/jn.109.109785", "19656855"]}, {"Citation": "Smith A., Giunta B., Bickford P.C., Fountain M., Tan J., Shytle R.D. Nanolipidic Particles Improve the Bioavailability and Alpha-Secretase Inducing Ability of Epigallocatechin-3-Gallate (EGCG) for the Treatment of Alzheimer\u2019s Disease. Int. J. Pharm. 2010;389:207\u2013212. doi: 10.1016/j.ijpharm.2010.01.012.", "ArticleIdList": ["10.1016/j.ijpharm.2010.01.012", "PMC5831366", "20083179"]}, {"Citation": "Nalivaeva N.N., Zhuravin I.A., Turner A.J. Neprilysin Expression and Functions in Development, Ageing and Disease. Mech. Ageing Dev. 2020;192:111363. doi: 10.1016/j.mad.2020.111363.", "ArticleIdList": ["10.1016/j.mad.2020.111363", "PMC7519013", "32987038"]}, {"Citation": "Lee E.O., Kim S.E., Park H.K., Kang J.L., Chong Y.H. Extracellular HIV-1 Tat Upregulates TNF-\u03b1 Dependent MCP-1/CCL2 Production via Activation of ERK1/2 Pathway in Rat Hippocampal Slice Cultures: Inhibition by Resveratrol, a Polyphenolic Phytostilbene. Exp. Neurol. 2011;229:399\u2013408. doi: 10.1016/j.expneurol.2011.03.006.", "ArticleIdList": ["10.1016/j.expneurol.2011.03.006", "21419119"]}, {"Citation": "Braidy N., Jugder B.-E., Poljak A., Jayasena T., Mansour H., Nabavi S.M., Sachdev P., Grant R. Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer\u2019s Disease. Curr. Top. Med. Chem. 2016;16:1951\u20131960. doi: 10.2174/1568026616666160204121431.", "ArticleIdList": ["10.2174/1568026616666160204121431", "26845555"]}, {"Citation": "Filardo S., Di Pietro M., Mastromarino P., Sessa R. Therapeutic Potential of Resveratrol against Emerging Respiratory Viral Infections. Pharmacol. Ther. 2020;214:107613. doi: 10.1016/j.pharmthera.2020.107613.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107613", "32562826"]}, {"Citation": "Villalba J.M., Alca\u00edn F.J. Sirtuin Activators and Inhibitors. Biofactors. 2012;38:349\u2013359. doi: 10.1002/biof.1032.", "ArticleIdList": ["10.1002/biof.1032", "PMC3467333", "22730114"]}, {"Citation": "Ramdani L.H., Bachari K. Potential Therapeutic Effects of Resveratrol against SARS-CoV-2. Acta Virol. 2020;64:276\u2013280. doi: 10.4149/av_2020_309.", "ArticleIdList": ["10.4149/av_2020_309", "32985211"]}, {"Citation": "Wahedi H.M., Ahmad S., Abbasi S.W. Stilbene-Based Natural Compounds as Promising Drug Candidates against COVID-19. J. Biomol. Struct. Dyn. 2021;39:3225\u20133234. doi: 10.1080/07391102.2020.1762743.", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Siddiqui A., Dandawate P., Rub R., Padhye S., Aphale S., Moghe A., Jagyasi A., Venkateswara Swamy K., Singh B., Chatterjee A., et al. Novel Aza-Resveratrol Analogs: Synthesis, Characterization and Anticancer Activity against Breast Cancer Cell Lines. Bioorg. Med. Chem. Lett. 2013;23:635\u2013640. doi: 10.1016/j.bmcl.2012.12.002.", "ArticleIdList": ["10.1016/j.bmcl.2012.12.002", "23273518"]}, {"Citation": "Chatterjee A., Ronghe A., Padhye S.B., Spade D.A., Bhat N.K., Bhat H.K. Antioxidant Activities of Novel Resveratrol Analogs in Breast Cancer. J. Biochem. Mol. Toxicol. 2018;32:e21925. doi: 10.1002/jbt.21925.", "ArticleIdList": ["10.1002/jbt.21925", "28960787"]}, {"Citation": "Abdalla F., Nookala A., Padhye S.B., Kumar A., Bhat H.K. 4-(E)-{(p-Tolylimino)-Methylbenzene-1,2-Diol} (TIMBD) Suppresses HIV1-Gp120 Mediated Production of IL6 and IL8 but Not CCL5. Sci. Rep. 2017;7:8129. doi: 10.1038/s41598-017-08332-z.", "ArticleIdList": ["10.1038/s41598-017-08332-z", "PMC5557832", "28811543"]}, {"Citation": "Xia C., Cai Y., Li S., Yang J., Xiao G. Curcumin Increases HSP70 Expression in Primary Rat Cortical Neuronal Apoptosis Induced by Gp120 V3 Loop Peptide. Neurochem. Res. 2015;40:1996\u20132005. doi: 10.1007/s11064-015-1695-x.", "ArticleIdList": ["10.1007/s11064-015-1695-x", "26294283"]}, {"Citation": "Zhao S., Yang J., Han X., Gong Y., Rao S., Wu B., Yi Z., Zou L., Jia T., Li L., et al. Effects of Nanoparticle-Encapsulated Curcumin on HIV-Gp120-Associated Neuropathic Pain Induced by the P2X3 Receptor in Dorsal Root Ganglia. Brain Res. Bull. 2017;135:53\u201361. doi: 10.1016/j.brainresbull.2017.09.011.", "ArticleIdList": ["10.1016/j.brainresbull.2017.09.011", "28962965"]}, {"Citation": "Prasad S., Tyagi A.K. Curcumin and Its Analogues: A Potential Natural Compound against HIV Infection and AIDS. Food Funct. 2015;6:3412\u20133419. doi: 10.1039/C5FO00485C.", "ArticleIdList": ["10.1039/C5FO00485C", "26404185"]}, {"Citation": "Zahedipour F., Hosseini S.A., Sathyapalan T., Majeed M., Jamialahmadi T., Al-Rasadi K., Banach M., Sahebkar A. Potential Effects of Curcumin in the Treatment of COVID-19 Infection. Phytother. Res. 2020;34:2911\u20132920. doi: 10.1002/ptr.6738.", "ArticleIdList": ["10.1002/ptr.6738", "PMC7276879", "32430996"]}, {"Citation": "Soni V.K., Mehta A., Ratre Y.K., Tiwari A.K., Amit A., Singh R.P., Sonkar S.C., Chaturvedi N., Shukla D., Vishvakarma N.K. Curcumin, a Traditional Spice Component, Can Hold the Promise against COVID-19? Eur. J. Pharm. 2020;886:173551. doi: 10.1016/j.ejphar.2020.173551.", "ArticleIdList": ["10.1016/j.ejphar.2020.173551", "PMC7832734", "32931783"]}, {"Citation": "Goozee K.G., Shah T.M., Sohrabi H.R., Rainey-Smith S.R., Brown B., Verdile G., Martins R.N. Examining the Potential Clinical Value of Curcumin in the Prevention and Diagnosis of Alzheimer\u2019s Disease. Br. J. Nutr. 2016;115:449\u2013465. doi: 10.1017/S0007114515004687.", "ArticleIdList": ["10.1017/S0007114515004687", "26652155"]}, {"Citation": "Xu X.-Y., Meng X., Li S., Gan R.-Y., Li Y., Li H.-B. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients. 2018;10:1553. doi: 10.3390/nu10101553.", "ArticleIdList": ["10.3390/nu10101553", "PMC6213156", "30347782"]}, {"Citation": "Sabirzhanov B., Stoica B.A., Hanscom M., Piao C.-S., Faden A.I. Over-Expression of HSP70 Attenuates Caspase-Dependent and Caspase-Independent Pathways and Inhibits Neuronal Apoptosis. J. Neurochem. 2012;123:542\u2013554. doi: 10.1111/j.1471-4159.2012.07927.x.", "ArticleIdList": ["10.1111/j.1471-4159.2012.07927.x", "PMC3753080", "22909049"]}, {"Citation": "Aridon P., Geraci F., Turturici G., D\u2019Amelio M., Savettieri G., Sconzo G. Protective Role of Heat Shock Proteins in Parkinson\u2019s Disease. Neurodegener. Dis. 2011;8:155\u2013168. doi: 10.1159/000321548.", "ArticleIdList": ["10.1159/000321548", "21212626"]}, {"Citation": "Shen L.-L., Jiang M.-L., Liu S.-S., Cai M.-C., Hong Z.-Q., Lin L.-Q., Xing Y.-Y., Chen G.-L., Pan R., Yang L.-J., et al. Curcumin Improves Synaptic Plasticity Impairment Induced by HIV-1gp120 V3 Loop. Neural Regen. Res. 2015;10:925\u2013931. doi: 10.4103/1673-5374.158358.", "ArticleIdList": ["10.4103/1673-5374.158358", "PMC4498354", "26199609"]}, {"Citation": "Tang H., Pan R., Fang W., Xing Y., Chen D., Chen X., Yu Y., Wang J., Gong Z., Xiong G., et al. Curcumin Ameliorates Hippocampal Neuron Damage Induced by Human Immunodeficiency Virus-1. Neural Regen. Res. 2013;8:1368\u20131375. doi: 10.3969/j.issn.1673-5374.2013.15.003.", "ArticleIdList": ["10.3969/j.issn.1673-5374.2013.15.003", "PMC4107768", "25206431"]}, {"Citation": "Thimmulappa R.K., Mudnakudu-Nagaraju K.K., Shivamallu C., Subramaniam K.J.T., Radhakrishnan A., Bhojraj S., Kuppusamy G. Antiviral and Immunomodulatory Activity of Curcumin: A Case for Prophylactic Therapy for COVID-19. Heliyon. 2021;7:e06350. doi: 10.1016/j.heliyon.2021.e06350.", "ArticleIdList": ["10.1016/j.heliyon.2021.e06350", "PMC7899028", "33655086"]}, {"Citation": "Maurya V.K., Kumar S., Prasad A.K., Bhatt M.L.B., Saxena S.K. Structure-Based Drug Designing for Potential Antiviral Activity of Selected Natural Products from Ayurveda against SARS-CoV-2 Spike Glycoprotein and Its Cellular Receptor. Virusdisease. 2020;31:179\u2013193. doi: 10.1007/s13337-020-00598-8.", "ArticleIdList": ["10.1007/s13337-020-00598-8", "PMC7245990", "32656311"]}, {"Citation": "Keflie T.S., Biesalski H.K. Micronutrients and Bioactive Substances: Their Potential Roles in Combating COVID-19. Nutrition. 2021;84:111103. doi: 10.1016/j.nut.2020.111103.", "ArticleIdList": ["10.1016/j.nut.2020.111103", "PMC7717879", "33450678"]}, {"Citation": "Teixeira N.d.S.C.C.d.A., Pereira B.d.M., Oliveira I.K.F., Lima C.H.R., de Carvalho C.M.R.G., Nunes I.F.d.O.C., Costa D.L., Paiva A.d.A. Effect of Vitamin D3 Supplementation on HIV-Infected Adults: A Systematic ReviewVitamin D\u0292 Supplementation on HIV-Infected Adults: A Systematic Review. Nutr. Hosp. 2019;36:1205\u20131212. doi: 10.20960/nh.02647.", "ArticleIdList": ["10.20960/nh.02647", "31526009"]}, {"Citation": "Mansueto P., Seidita A., Vitale G., Gangemi S., Iaria C., Cascio A. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. BioMed Res. Int. 2015;2015:735615. doi: 10.1155/2015/735615.", "ArticleIdList": ["10.1155/2015/735615", "PMC4426898", "26000302"]}, {"Citation": "Sudfeld C.R., Mugusi F., Aboud S., Nagu T.J., Wang M., Fawzi W.W. Efficacy of Vitamin D3 Supplementation in Reducing Incidence of Pulmonary Tuberculosis and Mortality among HIV-Infected Tanzanian Adults Initiating Antiretroviral Therapy: Study Protocol for a Randomized Controlled Trial. Trials. 2017;18:66. doi: 10.1186/s13063-017-1819-5.", "ArticleIdList": ["10.1186/s13063-017-1819-5", "PMC5301352", "28183335"]}, {"Citation": "Sudfeld C.R., Manji K.P., Duggan C.P., Aboud S., Muhihi A., Sando D.M., Al-Beity F.M.A., Wang M., Fawzi W.W. Effect of Maternal Vitamin D3 Supplementation on Maternal Health, Birth Outcomes, and Infant Growth among HIV-Infected Tanzanian Pregnant Women: Study Protocol for a Randomized Controlled Trial. Trials. 2017;18:411. doi: 10.1186/s13063-017-2157-3.", "ArticleIdList": ["10.1186/s13063-017-2157-3", "PMC5584035", "28870263"]}, {"Citation": "Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano J.L., Bhattoa H.P. Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12:988. doi: 10.3390/nu12040988.", "ArticleIdList": ["10.3390/nu12040988", "PMC7231123", "32252338"]}, {"Citation": "Dhama K., Sharun K., Tiwari R., Dadar M., Malik Y.S., Singh K.P., Chaicumpa W. COVID-19, an Emerging Coronavirus Infection: Advances and Prospects in Designing and Developing Vaccines, Immunotherapeutics, and Therapeutics. Hum. Vaccines Immunother. 2020;16:1232\u20131238. doi: 10.1080/21645515.2020.1735227.", "ArticleIdList": ["10.1080/21645515.2020.1735227", "PMC7103671", "32186952"]}, {"Citation": "Carter S.J., Baranauskas M.N., Fly A.D. Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID-19 Pandemic. Obesity. 2020;28:1176\u20131177. doi: 10.1002/oby.22838.", "ArticleIdList": ["10.1002/oby.22838", "PMC7311254", "32299148"]}, {"Citation": "de Barros Viana M., Ros\u00e1rio B.D.A., de F\u00e1tima Santana de Nazar\u00e9 M., Estadella D., Ribeiro D.A., Socorro de Barros Viana G. COVID-19 in Age-Related Neurodegenerative Diseases: Is There a Role for Vitamin D3 as a Possible Therapeutic Strategy? Rev. Neurosci. 2021;32:235\u2013247. doi: 10.1515/revneuro-2020-0074.", "ArticleIdList": ["10.1515/revneuro-2020-0074", "33185582"]}, {"Citation": "Liu G., Hong T., Yang J. A Single Large Dose of Vitamin D Could Be Used as a Means of Coronavirus Disease 2019 Prevention and Treatment. Drug Des. Dev. Ther. 2020;14:3429\u20133434. doi: 10.2147/DDDT.S271754.", "ArticleIdList": ["10.2147/DDDT.S271754", "PMC7457388", "32904593"]}, {"Citation": "Giunta B., Zhou Y., Hou H., Rrapo E., Fernandez F., Tan J. HIV-1 TAT Inhibits Microglial Phagocytosis of A\u03b2 Peptide. Int. J. Clin. Exp. Pathol. 2008;1:260\u2013275.", "ArticleIdList": ["PMC2480563", "18784813"]}, {"Citation": "Ranjit S., Kodidela S., Sinha N., Chauhan S., Kumar S. Extracellular Vesicles from Human Papilloma Virus-Infected Cervical Cancer Cells Enhance HIV-1 Replication in Differentiated U1 Cell Line. Viruses. 2020;12:239. doi: 10.3390/v12020239.", "ArticleIdList": ["10.3390/v12020239", "PMC7077309", "32098055"]}, {"Citation": "Zhi K., Kumar A., Raji B., Kochat H., Kumar S. Formulation, Manufacturing and Regulatory Strategies for Extracellular Vesicles-Based Drug Products for Targeted Therapy of Central Nervous System Diseases. Expert Rev. Precis. Med. Drug Dev. 2020;5:469\u2013481. doi: 10.1080/23808993.2020.1812382.", "ArticleIdList": ["10.1080/23808993.2020.1812382"]}, {"Citation": "Kumar A., Kodidela S., Tadrous E., Cory T.J., Walker C.M., Smith A.M., Mukherjee A., Kumar S. Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention. Viruses. 2020;12:887. doi: 10.3390/v12080887.", "ArticleIdList": ["10.3390/v12080887", "PMC7472073", "32823684"]}, {"Citation": "Elmore S. Apoptosis: A Review of Programmed Cell Death. Toxicol. Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337.", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: Controlled Demolition at the Cellular Level. Nat. Rev. Mol. Cell Biol. 2008;9:231\u2013241. doi: 10.1038/nrm2312.", "ArticleIdList": ["10.1038/nrm2312", "18073771"]}, {"Citation": "Clayton A., Harris C.L., Court J., Mason M.D., Morgan B.P. Antigen-Presenting Cell Exosomes Are Protected from Complement-Mediated Lysis by Expression of CD55 and CD59. Eur. J. Immunol. 2003;33:522\u2013531. doi: 10.1002/immu.200310028.", "ArticleIdList": ["10.1002/immu.200310028", "12645951"]}, {"Citation": "Kim M.S., Haney M.J., Zhao Y., Yuan D., Deygen I., Klyachko N.L., Kabanov A.V., Batrakova E.V. Engineering Macrophage-Derived Exosomes for Targeted Paclitaxel Delivery to Pulmonary Metastases: In Vitro and in Vivo Evaluations. Nanomedicine. 2018;14:195\u2013204. doi: 10.1016/j.nano.2017.09.011.", "ArticleIdList": ["10.1016/j.nano.2017.09.011", "28982587"]}, {"Citation": "Piffoux M., Silva A.K.A., Wilhelm C., Gazeau F., Tareste D. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. ACS Nano. 2018;12:6830\u20136842. doi: 10.1021/acsnano.8b02053.", "ArticleIdList": ["10.1021/acsnano.8b02053", "29975503"]}, {"Citation": "Meng W., He C., Hao Y., Wang L., Li L., Zhu G. Prospects and Challenges of Extracellular Vesicle-Based Drug Delivery System: Considering Cell Source. Drug Deliv. 2020;27:585\u2013598. doi: 10.1080/10717544.2020.1748758.", "ArticleIdList": ["10.1080/10717544.2020.1748758", "PMC7178886", "32264719"]}, {"Citation": "Claridge B., Lozano J., Poh Q.H., Greening D.W. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front. Cell Dev. Biol. 2021;9:734720. doi: 10.3389/fcell.2021.734720.", "ArticleIdList": ["10.3389/fcell.2021.734720", "PMC8488228", "34616741"]}, {"Citation": "Herrmann I.K., Wood M.J.A., Fuhrmann G. Extracellular Vesicles as a Next-Generation Drug Delivery Platform. Nat. Nanotechnol. 2021;16:748\u2013759. doi: 10.1038/s41565-021-00931-2.", "ArticleIdList": ["10.1038/s41565-021-00931-2", "34211166"]}, {"Citation": "Massaro C., Sgueglia G., Frattolillo V., Baglio S.R., Altucci L., Dell\u2019Aversana C. Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies. Pharmaceutics. 2020;12:980. doi: 10.3390/pharmaceutics12100980.", "ArticleIdList": ["10.3390/pharmaceutics12100980", "PMC7589909", "33081417"]}, {"Citation": "Kodidela S., Gerth K., Sinha N., Kumar A., Kumar P., Kumar S. Circulatory Astrocyte and Neuronal EVs as Potential Biomarkers of Neurological Dysfunction in HIV-Infected Subjects and Alcohol/Tobacco Users. Diagnostics. 2020;10:349. doi: 10.3390/diagnostics10060349.", "ArticleIdList": ["10.3390/diagnostics10060349", "PMC7345258", "32481515"]}, {"Citation": "Kumar A., Kumar S. Inhibition of Extracellular Vesicle Pathway Using Neutral Sphingomyelinase Inhibitors as a Neuroprotective Treatment for Brain Injury. Neural Regen. Res. 2021;16:2349\u20132352. doi: 10.4103/1673-5374.313014.", "ArticleIdList": ["10.4103/1673-5374.313014", "PMC8374560", "33907005"]}, {"Citation": "Yuana Y., Sturk A., Nieuwland R. Extracellular Vesicles in Physiological and Pathological Conditions. Blood Rev. 2013;27:31\u201339. doi: 10.1016/j.blre.2012.12.002.", "ArticleIdList": ["10.1016/j.blre.2012.12.002", "23261067"]}, {"Citation": "Sanwlani R., Gangoda L. Role of Extracellular Vesicles in Cell Death and Inflammation. Cells. 2021;10:2663. doi: 10.3390/cells10102663.", "ArticleIdList": ["10.3390/cells10102663", "PMC8534608", "34685643"]}, {"Citation": "Haque S., Kodidela S., Gerth K., Hatami E., Verma N., Kumar S. Extracellular Vesicles in Smoking-Mediated HIV Pathogenesis and Their Potential Role in Biomarker Discovery and Therapeutic Interventions. Cells. 2020;9:864. doi: 10.3390/cells9040864.", "ArticleIdList": ["10.3390/cells9040864", "PMC7226815", "32252352"]}, {"Citation": "Rahman M.A., Patters B.J., Kodidela S., Kumar S. Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies. J. Neuroimmune Pharmacol. 2020;15:409\u2013421. doi: 10.1007/s11481-019-09848-z.", "ArticleIdList": ["10.1007/s11481-019-09848-z", "PMC6778718", "30955131"]}, {"Citation": "Gerth K., Kodidela S., Mahon M., Haque S., Verma N., Kumar S. Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell\u2013Cell Interactions. Int. J. Mol. Sci. 2019;20:6178. doi: 10.3390/ijms20246178.", "ArticleIdList": ["10.3390/ijms20246178", "PMC6940889", "31817878"]}, {"Citation": "Kodidela S., Gerth K., Haque S., Gong Y., Ismael S., Singh A., Tauheed I., Kumar S. Extracellular Vesicles: A Possible Link between HIV and Alzheimer\u2019s Disease-Like Pathology in HIV Subjects? Cells. 2019;8:968. doi: 10.3390/cells8090968.", "ArticleIdList": ["10.3390/cells8090968", "PMC6769601", "31450610"]}, {"Citation": "Mitchell M.J., Billingsley M.M., Haley R.M., Wechsler M.E., Peppas N.A., Langer R. Engineering Precision Nanoparticles for Drug Delivery. Nat. Rev. Drug Discov. 2021;20:101\u2013124. doi: 10.1038/s41573-020-0090-8.", "ArticleIdList": ["10.1038/s41573-020-0090-8", "PMC7717100", "33277608"]}, {"Citation": "Kirtane A.R., Verma M., Karandikar P., Furin J., Langer R., Traverso G. Nanotechnology Approaches for Global Infectious Diseases. Nat. Nanotechnol. 2021;16:369\u2013384. doi: 10.1038/s41565-021-00866-8.", "ArticleIdList": ["10.1038/s41565-021-00866-8", "33753915"]}, {"Citation": "Gong Y., Chowdhury P., Nagesh P.K.B., Cory T.J., Dezfuli C., Kodidela S., Singh A., Yallapu M.M., Kumar S. Nanotechnology Approaches for Delivery of Cytochrome P450 Substrates in HIV Treatment. Expert Opin. Drug Deliv. 2019;16:869\u2013882. doi: 10.1080/17425247.2019.1646725.", "ArticleIdList": ["10.1080/17425247.2019.1646725", "PMC7183141", "31328582"]}, {"Citation": "Schiborr C., Kocher A., Behnam D., Jandasek J., Toelstede S., Frank J. The Oral Bioavailability of Curcumin from Micronized Powder and Liquid Micelles Is Significantly Increased in Healthy Humans and Differs between Sexes. Mol. Nutr. Food Res. 2014;58:516\u2013527. doi: 10.1002/mnfr.201300724.", "ArticleIdList": ["10.1002/mnfr.201300724", "24402825"]}, {"Citation": "Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects. Cancer Epidemiol. Biomark. Prev. 2008;17:1411\u20131417. doi: 10.1158/1055-9965.EPI-07-2693.", "ArticleIdList": ["10.1158/1055-9965.EPI-07-2693", "PMC4138955", "18559556"]}, {"Citation": "Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers. Planta Med. 1998;64:353\u2013356. doi: 10.1055/s-2006-957450.", "ArticleIdList": ["10.1055/s-2006-957450", "9619120"]}, {"Citation": "Ringman J.M., Frautschy S.A., Teng E., Begum A.N., Bardens J., Beigi M., Gylys K.H., Badmaev V., Heath D.D., Apostolova L.G., et al. Oral Curcumin for Alzheimer\u2019s Disease: Tolerability and Efficacy in a 24-Week Randomized, Double Blind, Placebo-Controlled Study. Alzheimer\u2019s Res. Ther. 2012;4:43. doi: 10.1186/alzrt146.", "ArticleIdList": ["10.1186/alzrt146", "PMC3580400", "23107780"]}, {"Citation": "Kumar A., Zhou L., Zhi K., Raji B., Pernell S., Tadrous E., Kodidela S., Nookala A., Kochat H., Kumar S. Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles. Int. J. Mol. Sci. 2020;22:138. doi: 10.3390/ijms22010138.", "ArticleIdList": ["10.3390/ijms22010138", "PMC7795247", "33375558"]}, {"Citation": "Chen C., Sun M., Wang J., Su L., Lin J., Yan X. Active Cargo Loading into Extracellular Vesicles: Highlights the Heterogeneous Encapsulation Behaviour. J. Extracell. Vesicles. 2021;10:e12163. doi: 10.1002/jev2.12163.", "ArticleIdList": ["10.1002/jev2.12163", "PMC8558234", "34719860"]}, {"Citation": "Kodidela S., Wang Y., Patters B.J., Gong Y., Sinha N., Ranjit S., Gerth K., Haque S., Cory T., McArthur C., et al. Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers. J. Neuroimmune Pharmacol. 2020;15:501\u2013519. doi: 10.1007/s11481-019-09853-2.", "ArticleIdList": ["10.1007/s11481-019-09853-2", "PMC7183142", "31065972"]}, {"Citation": "Th\u00e9ry C., Witwer K.W., Aikawa E., Alcaraz M.J., Anderson J.D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin-Smith G.K., et al. Minimal Information for Studies of Extracellular Vesicles 2018 (MISEV2018): A Position Statement of the International Society for Extracellular Vesicles and Update of the MISEV2014 Guidelines. J. Extracell. Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750.", "ArticleIdList": ["10.1080/20013078.2018.1535750", "PMC6322352", "30637094"]}, {"Citation": "Haraszti R.A., Miller R., Stoppato M., Sere Y.Y., Coles A., Didiot M.-C., Wollacott R., Sapp E., Dubuke M.L., Li X., et al. Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity. Mol. Ther. 2018;26:2838\u20132847. doi: 10.1016/j.ymthe.2018.09.015.", "ArticleIdList": ["10.1016/j.ymthe.2018.09.015", "PMC6277553", "30341012"]}, {"Citation": "Ng K.S., Smith J.A., McAteer M.P., Mead B.E., Ware J., Jackson F.O., Carter A., Ferreira L., Bure K., Rowley J.A., et al. Bioprocess Decision Support Tool for Scalable Manufacture of Extracellular Vesicles. Biotechnol. Bioeng. 2019;116:307\u2013319. doi: 10.1002/bit.26809.", "ArticleIdList": ["10.1002/bit.26809", "PMC6322973", "30063243"]}, {"Citation": "Li P., Kaslan M., Lee S.H., Yao J., Gao Z. Progress in Exosome Isolation Techniques. Theranostics. 2017;7:789\u2013804. doi: 10.7150/thno.18133.", "ArticleIdList": ["10.7150/thno.18133", "PMC5327650", "28255367"]}, {"Citation": "Vader P., Mol E.A., Pasterkamp G., Schiffelers R.M. Extracellular Vesicles for Drug Delivery. Adv. Drug Deliv. Rev. 2016;106:148\u2013156. doi: 10.1016/j.addr.2016.02.006.", "ArticleIdList": ["10.1016/j.addr.2016.02.006", "26928656"]}, {"Citation": "Kim M.S., Haney M.J., Zhao Y., Mahajan V., Deygen I., Klyachko N.L., Inskoe E., Piroyan A., Sokolsky M., Okolie O., et al. Development of Exosome-Encapsulated Paclitaxel to Overcome MDR in Cancer Cells. Nanomedicine. 2016;12:655\u2013664. doi: 10.1016/j.nano.2015.10.012.", "ArticleIdList": ["10.1016/j.nano.2015.10.012", "PMC4809755", "26586551"]}, {"Citation": "Haraszti R.A., Coles A., Aronin N., Khvorova A., Didiot M.-C. Loading of Extracellular Vesicles with Chemically Stabilized Hydrophobic SiRNAs for the Treatment of Disease in the Central Nervous System. Bio-Protocol. 2017;7:e2338. doi: 10.21769/BioProtoc.2338.", "ArticleIdList": ["10.21769/BioProtoc.2338", "PMC5580947", "28868334"]}, {"Citation": "Didiot M.-C., Hall L.M., Coles A.H., Haraszti R.A., Godinho B.M., Chase K., Sapp E., Ly S., Alterman J.F., Hassler M.R., et al. Exosome-Mediated Delivery of Hydrophobically Modified SiRNA for Huntingtin MRNA Silencing. Mol. Ther. 2016;24:1836\u20131847. doi: 10.1038/mt.2016.126.", "ArticleIdList": ["10.1038/mt.2016.126", "PMC5112038", "27506293"]}, {"Citation": "Brossa A., Tapparo M., Fonsato V., Papadimitriou E., Delena M., Camussi G., Bussolati B. Coincubation as MiR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs. Pharmaceutics. 2021;13:76. doi: 10.3390/pharmaceutics13010076.", "ArticleIdList": ["10.3390/pharmaceutics13010076", "PMC7826638", "33429869"]}, {"Citation": "Sun D., Zhuang X., Xiang X., Liu Y., Zhang S., Liu C., Barnes S., Grizzle W., Miller D., Zhang H.-G. A Novel Nanoparticle Drug Delivery System: The Anti-Inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes. Mol. Ther. 2010;18:1606\u20131614. doi: 10.1038/mt.2010.105.", "ArticleIdList": ["10.1038/mt.2010.105", "PMC2956928", "20571541"]}, {"Citation": "Tian T., Zhang H.-X., He C.-P., Fan S., Zhu Y.-L., Qi C., Huang N.-P., Xiao Z.-D., Lu Z.-H., Tannous B.A., et al. Surface Functionalized Exosomes as Targeted Drug Delivery Vehicles for Cerebral Ischemia Therapy. Biomaterials. 2018;150:137\u2013149. doi: 10.1016/j.biomaterials.2017.10.012.", "ArticleIdList": ["10.1016/j.biomaterials.2017.10.012", "29040874"]}, {"Citation": "Gomari H., Forouzandeh Moghadam M., Soleimani M. Targeted Cancer Therapy Using Engineered Exosome as a Natural Drug Delivery Vehicle. OncoTargets Ther. 2018;11:5753\u20135762. doi: 10.2147/OTT.S173110.", "ArticleIdList": ["10.2147/OTT.S173110", "PMC6140699", "30254468"]}, {"Citation": "Tran P.H.L., Wang T., Yin W., Tran T.T.D., Nguyen T.N.G., Lee B.-J., Duan W. Aspirin-Loaded Nanoexosomes as Cancer Therapeutics. Int. J. Pharm. 2019;572:118786. doi: 10.1016/j.ijpharm.2019.118786.", "ArticleIdList": ["10.1016/j.ijpharm.2019.118786", "31669214"]}, {"Citation": "Li Y.-J., Wu J.-Y., Wang J.-M., Hu X.-B., Cai J.-X., Xiang D.-X. Gemcitabine Loaded Autologous Exosomes for Effective and Safe Chemotherapy of Pancreatic Cancer. Acta Biomater. 2020;101:519\u2013530. doi: 10.1016/j.actbio.2019.10.022.", "ArticleIdList": ["10.1016/j.actbio.2019.10.022", "31629893"]}, {"Citation": "Yang T., Martin P., Fogarty B., Brown A., Schurman K., Phipps R., Yin V.P., Lockman P., Bai S. Exosome Delivered Anticancer Drugs across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio. Pharm. Res. 2015;32:2003\u20132014. doi: 10.1007/s11095-014-1593-y.", "ArticleIdList": ["10.1007/s11095-014-1593-y", "PMC4520542", "25609010"]}, {"Citation": "Liu T., Zhang X., Du L., Wang Y., Liu X., Tian H., Wang L., Li P., Zhao Y., Duan W., et al. Exosome-Transmitted MiR-128-3p Increase Chemosensitivity of Oxaliplatin-Resistant Colorectal Cancer. Mol. Cancer. 2019;18:43. doi: 10.1186/s12943-019-0981-7.", "ArticleIdList": ["10.1186/s12943-019-0981-7", "PMC6423768", "30890168"]}, {"Citation": "Katakowski M., Buller B., Zheng X., Lu Y., Rogers T., Osobamiro O., Shu W., Jiang F., Chopp M. Exosomes from Marrow Stromal Cells Expressing MiR-146b Inhibit Glioma Growth. Cancer Lett. 2013;335:201\u2013204. doi: 10.1016/j.canlet.2013.02.019.", "ArticleIdList": ["10.1016/j.canlet.2013.02.019", "PMC3665755", "23419525"]}, {"Citation": "Kosaka N., Iguchi H., Yoshioka Y., Hagiwara K., Takeshita F., Ochiya T. Competitive Interactions of Cancer Cells and Normal Cells via Secretory MicroRNAs. J. Biol. Chem. 2012;287:1397\u20131405. doi: 10.1074/jbc.M111.288662.", "ArticleIdList": ["10.1074/jbc.M111.288662", "PMC3256909", "22123823"]}, {"Citation": "Ohno S., Takanashi M., Sudo K., Ueda S., Ishikawa A., Matsuyama N., Fujita K., Mizutani T., Ohgi T., Ochiya T., et al. Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. Mol. Ther. 2013;21:185\u2013191. doi: 10.1038/mt.2012.180.", "ArticleIdList": ["10.1038/mt.2012.180", "PMC3538304", "23032975"]}, {"Citation": "Bellavia D., Raimondo S., Calabrese G., Forte S., Cristaldi M., Patinella A., Memeo L., Manno M., Raccosta S., Diana P., et al. Interleukin 3-Receptor Targeted Exosomes Inhibit in Vitro and in Vivo Chronic Myelogenous Leukemia Cell Growth. Theranostics. 2017;7:1333\u20131345. doi: 10.7150/thno.17092.", "ArticleIdList": ["10.7150/thno.17092", "PMC5399597", "28435469"]}, {"Citation": "Jeong K., Yu Y.J., You J.Y., Rhee W.J., Kim J.A. Exosome-Mediated MicroRNA-497 Delivery for Anti-Cancer Therapy in a Microfluidic 3D Lung Cancer Model. Lab Chip. 2020;20:548\u2013557. doi: 10.1039/C9LC00958B.", "ArticleIdList": ["10.1039/C9LC00958B", "31942592"]}, {"Citation": "Pomatto M.A.C., Bussolati B., D\u2019Antico S., Ghiotto S., Tetta C., Brizzi M.F., Camussi G. Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor MiRNAs. Mol. Ther. Methods Clin. Dev. 2019;13:133\u2013144. doi: 10.1016/j.omtm.2019.01.001.", "ArticleIdList": ["10.1016/j.omtm.2019.01.001", "PMC6370572", "30788382"]}, {"Citation": "Zhou W., Zhou Y., Chen X., Ning T., Chen H., Guo Q., Zhang Y., Liu P., Zhang Y., Li C., et al. Pancreatic Cancer-Targeting Exosomes for Enhancing Immunotherapy and Reprogramming Tumor Microenvironment. Biomaterials. 2021;268:120546. doi: 10.1016/j.biomaterials.2020.120546.", "ArticleIdList": ["10.1016/j.biomaterials.2020.120546", "33253966"]}, {"Citation": "Hadla M., Palazzolo S., Corona G., Caligiuri I., Canzonieri V., Toffoli G., Rizzolio F. Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models. Nanomedicine. 2016;11:2431\u20132441. doi: 10.2217/nnm-2016-0154.", "ArticleIdList": ["10.2217/nnm-2016-0154", "27558906"]}, {"Citation": "Yang Z., Shi J., Xie J., Wang Y., Sun J., Liu T., Zhao Y., Zhao X., Wang X., Ma Y., et al. Large-Scale Generation of Functional MRNA-Encapsulating Exosomes via Cellular Nanoporation. Nat. Biomed. Eng. 2020;4:69\u201383. doi: 10.1038/s41551-019-0485-1.", "ArticleIdList": ["10.1038/s41551-019-0485-1", "PMC7080209", "31844155"]}, {"Citation": "Yuana Y., Balachandran B., van der Wurff-Jacobs K.M.G., Schiffelers R.M., Moonen C.T. Potential Use of Extracellular Vesicles Generated by Microbubble-Assisted Ultrasound as Drug Nanocarriers for Cancer Treatment. Int. J. Mol. Sci. 2020;21:3024. doi: 10.3390/ijms21083024.", "ArticleIdList": ["10.3390/ijms21083024", "PMC7216118", "32344752"]}, {"Citation": "Haney M.J., Klyachko N.L., Zhao Y., Gupta R., Plotnikova E.G., He Z., Patel T., Piroyan A., Sokolsky M., Kabanov A.V., et al. Exosomes as Drug Delivery Vehicles for Parkinson\u2019s Disease Therapy. J. Control Release. 2015;207:18\u201330. doi: 10.1016/j.jconrel.2015.03.033.", "ArticleIdList": ["10.1016/j.jconrel.2015.03.033", "PMC4430381", "25836593"]}, {"Citation": "Oshchepkova A., Neumestova A., Matveeva V., Artemyeva L., Morozova K., Kiseleva E., Zenkova M., Vlassov V. Cytochalasin-B-Inducible Nanovesicle Mimics of Natural Extracellular Vesicles That Are Capable of Nucleic Acid Transfer. Micromachines. 2019;10:750. doi: 10.3390/mi10110750.", "ArticleIdList": ["10.3390/mi10110750", "PMC6915531", "31683842"]}, {"Citation": "Haney M.J., Klyachko N.L., Harrison E.B., Zhao Y., Kabanov A.V., Batrakova E.V. TPP1 Delivery to Lysosomes with Extracellular Vesicles and Their Enhanced Brain Distribution in the Animal Model of Batten Disease. Adv. Healthc. Mater. 2019;8:1801271. doi: 10.1002/adhm.201801271.", "ArticleIdList": ["10.1002/adhm.201801271", "PMC6584948", "30997751"]}, {"Citation": "Fuhrmann G., Serio A., Mazo M., Nair R., Stevens M.M. Active Loading into Extracellular Vesicles Significantly Improves the Cellular Uptake and Photodynamic Effect of Porphyrins. J. Control Release. 2015;205:35\u201344. doi: 10.1016/j.jconrel.2014.11.029.", "ArticleIdList": ["10.1016/j.jconrel.2014.11.029", "25483424"]}, {"Citation": "Izadpanah M., Dargahi L., Ai J., Asgari Taei A., Ebrahimi Barough S., Mowla S.J., TavoosiDana G., Farahmandfar M. Extracellular Vesicles as a Neprilysin Delivery System Memory Improvement in Alzheimer\u2019s Disease. Iran. J. Pharm. Res. 2020;19:45\u201360. doi: 10.22037/ijpr.2020.112062.13508.", "ArticleIdList": ["10.22037/ijpr.2020.112062.13508", "PMC7667544", "33224210"]}, {"Citation": "Hajipour H., Farzadi L., Roshangar L., Latifi Z., Kahroba H., Shahnazi V., Hamdi K., Ghasemzadeh A., Fattahi A., Nouri M. A Human Chorionic Gonadotropin (HCG) Delivery Platform Using Engineered Uterine Exosomes to Improve Endometrial Receptivity. Life Sci. 2021;275:119351. doi: 10.1016/j.lfs.2021.119351.", "ArticleIdList": ["10.1016/j.lfs.2021.119351", "33737084"]}, {"Citation": "Lamichhane T.N., Jeyaram A., Patel D.B., Parajuli B., Livingston N.K., Arumugasaamy N., Schardt J.S., Jay S.M. Oncogene Knockdown via Active Loading of Small RNAs into Extracellular Vesicles by Sonication. Cell. Mol. Bioeng. 2016;9:315\u2013324. doi: 10.1007/s12195-016-0457-4.", "ArticleIdList": ["10.1007/s12195-016-0457-4", "PMC5084850", "27800035"]}, {"Citation": "Haney M.J., Zhao Y., Jin Y.S., Li S.M., Bago J.R., Klyachko N.L., Kabanov A.V., Batrakova E.V. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. J. Neuroimmune Pharmacol. 2020;15:487\u2013500. doi: 10.1007/s11481-019-09884-9.", "ArticleIdList": ["10.1007/s11481-019-09884-9", "31722094"]}, {"Citation": "Haque S., Kodidela S., Sinha N., Kumar P., Cory T.J., Kumar S. Differential Packaging of Inflammatory Cytokines/Chemokines and Oxidative Stress Modulators in U937 and U1 Macrophages-Derived Extracellular Vesicles upon Exposure to Tobacco Constituents. PLoS ONE. 2020;15:e0233054. doi: 10.1371/journal.pone.0233054.", "ArticleIdList": ["10.1371/journal.pone.0233054", "PMC7239484", "32433651"]}, {"Citation": "Zou X., Yuan M., Zhang T., Wei H., Xu S., Jiang N., Zheng N., Wu Z. Extracellular Vesicles Expressing a Single-Chain Variable Fragment of an HIV-1 Specific Antibody Selectively Target Env+ Tissues. Theranostics. 2019;9:5657\u20135671. doi: 10.7150/thno.33925.", "ArticleIdList": ["10.7150/thno.33925", "PMC6735399", "31534509"]}, {"Citation": "He R., Jiang Y., Shi Y., Liang J., Zhao L. Curcumin-Laden Exosomes Target Ischemic Brain Tissue and Alleviate Cerebral Ischemia-Reperfusion Injury by Inhibiting ROS-Mediated Mitochondrial Apoptosis. Mater. Sci. Eng. C Mater. Biol. Appl. 2020;117:111314. doi: 10.1016/j.msec.2020.111314.", "ArticleIdList": ["10.1016/j.msec.2020.111314", "32919674"]}, {"Citation": "Wang H., Sui H., Zheng Y., Jiang Y., Shi Y., Liang J., Zhao L. Curcumin-Primed Exosomes Potently Ameliorate Cognitive Function in AD Mice by Inhibiting Hyperphosphorylation of the Tau Protein through the AKT/GSK-3\u03b2 Pathway. Nanoscale. 2019;11:7481\u20137496. doi: 10.1039/C9NR01255A.", "ArticleIdList": ["10.1039/C9NR01255A", "30942233"]}, {"Citation": "Zhuang X., Xiang X., Grizzle W., Sun D., Zhang S., Axtell R.C., Ju S., Mu J., Zhang L., Steinman L., et al. Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-Inflammatory Drugs From the Nasal Region to the Brain. Mol. Ther. 2011;19:1769\u20131779. doi: 10.1038/mt.2011.164.", "ArticleIdList": ["10.1038/mt.2011.164", "PMC3188748", "21915101"]}, {"Citation": "Aqil F., Jeyabalan J., Agrawal A.K., Kyakulaga A.-H., Munagala R., Parker L., Gupta R.C. Exosomal Delivery of Berry Anthocyanidins for the Management of Ovarian Cancer. Food Funct. 2017;8:4100\u20134107. doi: 10.1039/C7FO00882A.", "ArticleIdList": ["10.1039/C7FO00882A", "28991298"]}, {"Citation": "Munagala R., Aqil F., Jeyabalan J., Agrawal A.K., Mudd A.M., Kyakulaga A.H., Singh I.P., Vadhanam M.V., Gupta R.C. Exosomal Formulation of Anthocyanidins against Multiple Cancer Types. Cancer Lett. 2017;393:94\u2013102. doi: 10.1016/j.canlet.2017.02.004.", "ArticleIdList": ["10.1016/j.canlet.2017.02.004", "PMC5837866", "28202351"]}, {"Citation": "Donoso-Quezada J., Guajardo-Flores D., Gonz\u00e1lez-Valdez J. Enhanced Exosome-Mediated Delivery of Black Bean Phytochemicals (Phaseolus vulgaris L.) for Cancer Treatment Applications. Biomed. Pharmacother. 2020;131:110771. doi: 10.1016/j.biopha.2020.110771.", "ArticleIdList": ["10.1016/j.biopha.2020.110771", "33152932"]}, {"Citation": "Aqil F., Kausar H., Agrawal A.K., Jeyabalan J., Kyakulaga A.-H., Munagala R., Gupta R. Exosomal Formulation Enhances Therapeutic Response of Celastrol against Lung Cancer. Exp. Mol. Pathol. 2016;101:12\u201321. doi: 10.1016/j.yexmp.2016.05.013.", "ArticleIdList": ["10.1016/j.yexmp.2016.05.013", "27235383"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "23"}, {"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "2", "Day": "25", "Hour": "1", "Minute": "5"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["35205044", "PMC8869385", "10.3390/biology11020177", "biology11020177"]}}], "PubmedBookArticle": []}